Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (441-450 of 509) with videos related to

Pageof 51
Sort By:
Open Forum Infectious Diseases|December 14, 2019
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
The Journal of Infectious Diseases|December 15, 2021
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 YearsIsabella C Schoepf, Christian W Thorball, Bruno Ledergerber, et al.
Lancet (London, England)|July 20, 2002
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesMatthias Egger, Margaret May, Geneviève Chêne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2023
Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal StudyEmma F Avery, Julia N Kleynhans, Bruno Ledergerber, et al.
AIDS (London, England)|March 17, 2018
Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan AfricaStefanie Kroeze, Pascale Ondoa, Cissy M Kityo, et al.
Open Forum Infectious Diseases|October 30, 2019
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
Plos One|January 8, 2026
Association of leukocyte count with death in people with HIV: A longitudinal study over 24 yearsZoe Klein, Sophia C Meyer, Isabella C Schoepf, et al.
The Lancet. Healthy Longevity|May 6, 2023
Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 yearsIsabella C Schoepf, Andrés Esteban-Cantos, Christian W Thorball, et al.
Pathogens & Immunity|January 31, 2022
Is France Once Again Looking for a Scapegoat?Michael M Lederman, Jeffrey S Flier, Peter Hale, et al.
Nature|November 1, 2023
Homogenizing out-of-plane cation composition in perovskite solar cellsZheng Liang, Yong Zhang, Huifen Xu, et al.
Pageof 51

Showing results (441-450 of 509) with videos related to

Sort By:
Pageof 51
Open Forum Infectious Diseases|December 14, 2019
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
The Journal of Infectious Diseases|December 15, 2021
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 YearsIsabella C Schoepf, Christian W Thorball, Bruno Ledergerber, et al.
Lancet (London, England)|July 20, 2002
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesMatthias Egger, Margaret May, Geneviève Chêne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2023
Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal StudyEmma F Avery, Julia N Kleynhans, Bruno Ledergerber, et al.
AIDS (London, England)|March 17, 2018
Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan AfricaStefanie Kroeze, Pascale Ondoa, Cissy M Kityo, et al.
Open Forum Infectious Diseases|October 30, 2019
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
Plos One|January 8, 2026
Association of leukocyte count with death in people with HIV: A longitudinal study over 24 yearsZoe Klein, Sophia C Meyer, Isabella C Schoepf, et al.
The Lancet. Healthy Longevity|May 6, 2023
Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 yearsIsabella C Schoepf, Andrés Esteban-Cantos, Christian W Thorball, et al.
Pathogens & Immunity|January 31, 2022
Is France Once Again Looking for a Scapegoat?Michael M Lederman, Jeffrey S Flier, Peter Hale, et al.
Nature|November 1, 2023
Homogenizing out-of-plane cation composition in perovskite solar cellsZheng Liang, Yong Zhang, Huifen Xu, et al.
Pageof 51